# Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer

> clinical trial · VERIFIED · 2026-07-14

Status: NOT_YET_RECRUITING · Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Condition: Advanced Biliary Tract Cancer(BTC)

- Company: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Sector: Advanced Biliary Tract Cancer(BTC)
- Primary source: https://clinicaltrials.gov/study/NCT07701122

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.